CATALOGO DEI PRODOTTI DELLA RICERCA

FERRARINI, Isacco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.532
NA - Nord America 2.378
AS - Asia 1.793
SA - Sud America 271
AF - Africa 98
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.095
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.315
RU - Federazione Russa 1.200
SG - Singapore 755
CN - Cina 391
IT - Italia 336
VN - Vietnam 230
GB - Regno Unito 229
DE - Germania 220
BR - Brasile 192
HK - Hong Kong 173
FR - Francia 104
FI - Finlandia 103
SE - Svezia 90
IE - Irlanda 86
KR - Corea 53
IN - India 42
ID - Indonesia 37
NL - Olanda 35
CA - Canada 33
PL - Polonia 28
AR - Argentina 25
ES - Italia 25
MX - Messico 23
NG - Nigeria 21
AT - Austria 20
AU - Australia 19
BJ - Benin 19
EC - Ecuador 18
TR - Turchia 18
ZA - Sudafrica 18
BD - Bangladesh 17
JP - Giappone 17
UA - Ucraina 13
IQ - Iraq 12
TG - Togo 10
CL - Cile 9
BE - Belgio 7
CO - Colombia 7
MA - Marocco 7
PT - Portogallo 7
IR - Iran 6
SC - Seychelles 6
CZ - Repubblica Ceca 5
PE - Perù 5
PY - Paraguay 5
SA - Arabia Saudita 5
TN - Tunisia 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
LT - Lituania 4
PK - Pakistan 4
BO - Bolivia 3
CH - Svizzera 3
IL - Israele 3
JM - Giamaica 3
KG - Kirghizistan 3
CG - Congo 2
DK - Danimarca 2
DZ - Algeria 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
KE - Kenya 2
KW - Kuwait 2
MT - Malta 2
NP - Nepal 2
PH - Filippine 2
PS - Palestinian Territory 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TW - Taiwan 2
UZ - Uzbekistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
EE - Estonia 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
HN - Honduras 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
LS - Lesotho 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
SN - Senegal 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 7.095
Salva come PNG Salva come JPEG
Città #
Dallas 436
Moscow 432
Singapore 421
San Jose 344
Ashburn 337
Hong Kong 170
Chandler 165
Southend 133
Verona 133
Munich 121
Beijing 96
Dublin 80
Ho Chi Minh City 75
Helsinki 69
Los Angeles 66
The Dalles 60
New York 53
Hanoi 44
Jacksonville 42
London 33
Buffalo 32
Santa Clara 31
Lawrence 28
Princeton 28
Council Bluffs 27
Milan 26
São Paulo 26
Woodbridge 26
Jakarta 25
Warsaw 25
Orem 24
Columbus 20
Jinan 20
Cotonou 19
Houston 19
Tianjin 19
Wilmington 19
Frankfurt am Main 16
Nanjing 16
Redondo Beach 16
Ann Arbor 15
Brooklyn 15
Redmond 15
Abuja 14
Seattle 14
Amsterdam 13
Lappeenranta 13
Melbourne 13
Shenyang 13
Sindelfingen 13
Tokyo 13
Chennai 12
Denver 12
Vienna 12
Zhengzhou 12
Falkenstein 11
Haiphong 11
Toronto 11
Turku 11
Changsha 10
Johannesburg 10
Lomé 10
Montreal 10
Nuremberg 10
Phoenix 10
Stockholm 10
Stuttgart 10
Ankara 9
Dong Ket 9
Fairfield 9
Seoul 9
Guangzhou 8
Hebei 8
Rio de Janeiro 8
Rome 8
San Francisco 8
Vicenza 8
Atlanta 7
Biên Hòa 7
Bologna 7
Guayaquil 7
Lagos 7
Padua 7
Vancouver 7
Brussels 6
Chicago 6
City of London 6
Da Nang 6
Hangzhou 6
Madrid 6
Mahé 6
Manchester 6
Mexico City 6
Paris 6
Querétaro 6
Redwood City 6
Trento 6
Washington 6
Barcelona 5
Bogotá 5
Totale 4.322
Salva come PNG Salva come JPEG
Nome #
Erectile Dysfunction after Allogeneic Hematopoietic Stem Cell Transplant: Results from a Single Center Experience 214
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 213
Chronic graft versus host disease is associated with erectile dysfunction in allogeneic hematopoietic stem cell transplant patients: a single-center experience 212
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 211
CXCL12 and [N33A]CXCL12 in 5637 and HeLa Cells: Regulating HER1 Phosphorylation via Calmodulin/Calcineurin 211
Synthetic PGI-2 (Iloprost) treatment in patients with resistant sclerodermic chronic GVHD (cGVHD) after Allogeneic Hematopoietic Stem Cell Transplantation 197
Activation of Protein Tyrosine Phosphatase Receptor Type γ Suppresses Mechanisms of Adhesion and Survival in Chronic Lymphocytic Leukemia Cells 192
BID and the α-bisabolol-triggered cell death program: converging on mitochondria and lysosomes 189
CXCR4- and BCR-triggered integrin activation in B-cell chronic lymphocytic leukemia cells depends on JAK2-activated Bruton's tyrosine kinase 188
A single amino acid substitution in CXCL12 confers functional selectivity at the beta-arrestin level 180
Efficient lysis of B-chronic lymphocytic leukemia cells by the plant-derived sesquiterpene alcohol α-bisabolol, a dual proapoptotic and antiautophagic agent 173
Efficacy of R-COMP in comparison to R-CHOP in patients with DLBCL: A systematic review and single-arm metanalysis 169
Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice 160
Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study 160
Decreased apoptotic priming and loss of BCL-2 dependence are functional hallmarks of Richter's syndrome 158
Classical Hodgkin lymphoma cells may promote an IL-17-enriched microenvironment 158
COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review 158
Case Report: Rapid renal response to venetoclax monotherapy in a CLL patient with secondary membranous glomerulonephritis 153
Immunologic evidence of a strong association between non-Hodgkin lymphoma and simian virus 40 150
Long-term remissions with Gilteritinib in early relapse after allogeneic stem cell transplantation of FLT3/NPM1 mutated acute myeloid leukemia 148
Monocyte-to-macrophage switch reversibly impaired by Ibrutinib. 142
Pembrolizumab as salvage treatment for T-cell/histiocyte-rich and Epstein-Barr virus-positive large B-cell lymphoma 137
CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic Leukemia 136
ONC201 and imipridones: Anti-cancer compounds with clinical efficacy. 123
Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study 122
An updated portrait of monocyte-macrophages in classical Hodgkin lymphoma 121
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study 120
IMMUNE THROMBOCYTOPENIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: CASE REPORT AND BRIEF OVERVIEW OF TREATMENT STRATEGIES 120
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study 120
Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome 118
West Nile Virus Encephalitis in Haematological Setting: Report of Two Cases and a Brief Review of the Literature 116
High prevalence of antibodies reacting to mimotopes of Simian virus 40 large T antigen, the oncoprotein, in serum samples of patients affected by non-Hodgkin lymphoma 109
ONC212 IS A NOVEL MITOCAN ACTING SYNERGISTICALLY WITH GLYCOLYSIS INHIBITION IN PANCREATIC CANCER 109
T CELL/HISTIOCYTE-RICH LARGE B-CELL LYMPHOMA: CLINICO-PATHOLOGICAL FEATURES AND RESPONSE TO IMMUNE CHECKPOINT INHIBITORS 105
The mitochondrial anti-apoptotic dependencies of hematologic malignancies: from disease biology to advances in precision medicine 104
Successful rechallenge with azacytidine and venetoclax after sustained treatment-free remission in a relapsed acute myeloid leukemia patient: a case report 104
Extracellular Vesicles based STAT3 delivery as innovative therapeutic approach to restore STAT3 signaling deficiency 103
A brisk peripheral T-cell reaction following rituximab treatment for follicular lymphoma 94
Venetoclax based regimens in octogenarian CLL patients: efficacy, safety and comparison to BTKi in a multicenter cohort 89
CATALASE BLOCKING INDUCES APOPTOSIS AND POTENTIATES VENETOCLAX-INDUCED CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 89
The Evolving Knowledge on T and NK Cells in Classic Hodgkin Lymphoma: Insights into Novel Subsets Populating the Immune Microenvironment 88
Real-world Outcomes of Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin-based Therapy 83
Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey 82
How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia 76
ONC212 is a Novel Mitocan Acting Synergistically with Glycolysis Inhibition in Pancreatic Cancer 76
Two Distinct Clinical Patterns of Ibrutinib-to-Venetoclax Transition in Relapsed Chronic Lymphocytic Leukemia Patients 76
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort 71
The Importance of Real-World Data in Evaluating the Safety of Biosimilars: A Descriptive Study of Clinical Practice in an Oncohematological Italian Population 69
ACTIVATION OF BCR SIGNALING REWIRES THE RESPONSE OF BCR-ASSOCIATED KINASES TO IBRUTINIB IN MANTLE CELL LYMPHOMA CELLS 68
Salvage treatment after covalent BTKi failure: An unmet need in clinical practice in Waldenstrom macroglobulinemia 67
Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma 66
CAT RS1001179 SINGLE NUCLEOTIDE POLYMORPHISM IDENTIFIES AN AGGRESSIVE CLINICAL BEHAVIOR IN CHRONIC LYMPHOCYTIC LEUKEMIA 64
Targeting CD19 in diffuse large B-cell lymphoma: An expert opinion paper 63
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies 62
BCR signaling activity stratifies patents with MCL with divergent clinical outcome 62
B-CELL RECEPTOR SIGNALING ACTIVITY IDENTIFIES PATIENTS WITH MANTLE CELL LYMPHOMA AT HIGHER RISK OF PROGRESSION 62
THE PROGNOSTIC SIGNIFICANCE OF MYC AND BCL2 PROTEIN DOUBLE EXPRESSION IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA, NOS, IN THE ABSENCE OF MYC REARRANGEMENT 56
Outcomes of younger patients with mantle‐cell lymphoma experiencing late relapse (>24 months): the LATE‐POD study 49
PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF THE B-CELL RECEPTOR SIGNALING IN MANTLE CELL LYMPHOMA 41
Pirtobrutinib in relapsed or refractory mantle cell lymphoma: outcomes from the compassionate use program in Italy 21
Renal dysfunction in symptomatic Waldenström macroglobulinaemia: A nationwide Italian multicentre study 7
Totale 7.184
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.448
article - articoli 20.803
book - libri 0
conference - conferenze 1.041
curatela - curatele 0
other - altro 604
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.896
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 0 0 0 0 0 0 0 5 14 19
2021/2022219 12 50 2 10 35 4 7 12 4 14 12 57
2022/2023500 30 67 37 92 38 112 11 36 57 6 7 7
2023/2024327 11 30 49 34 25 41 20 26 9 20 49 13
2024/20251.268 46 49 72 180 55 84 84 86 184 83 124 221
2025/20264.362 216 393 290 632 1.302 279 377 276 377 220 0 0
Totale 7.184